Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs)
Editorial Group: Cochrane Depression, Anxiety and Neurosis Group
Published Online: 19 JUL 2006
Assessed as up-to-date: 12 JUL 2000
Copyright © 2006 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Barbui C, Hotopf M, Freemantle N, Boynton J, Churchill R, Eccles M, Geddes J, Hardy R, Lewis G, Mason J. Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD002791. DOI: 10.1002/14651858.CD002791.pub2.
- Publication Status: Withdrawn from publication for reasons stated in the review
- Published Online: 19 JUL 2006
This version of the review has been withdrawn. During the course of updating, the review has been split into a number of separate reviews examining head to head comparisons as part of the Multiple meta-Analyses of New Generation Antidepressants (MANGA Study). These individual reviews will then be combined in a mega-review using multiple treatment model methodology. To view the published versions of this article, please click the 'Other versions' tab.